Lv4
480 积分 2024-03-15 加入
Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases
1天前
待确认
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
2天前
已完结
Neoadjuvant low-dose radiotherapy plus durvalumab and chemotherapy for potentially resectable stage III NSCLC: A phase Ib dose-escalation study
2天前
已完结
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
2天前
已完结
Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer
2个月前
已完结
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer
2个月前
已完结
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial
2个月前
已完结
Lung cancer
7个月前
已完结
Update 2020: Management of Non-Small Cell Lung Cancer
7个月前
已完结
皖公网安备34019202002308
